These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2856771)

  • 41. Malignant hypertension in a child with hemolytic-uremic syndrome treated with captopril.
    Monnens L; Drayer J; De Jong M
    Acta Paediatr Scand; 1981 Jul; 70(4):583-5. PubMed ID: 7032189
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The relationship between hepatitis B and renin-angiotensin-aldosterone system].
    Liu Z; Tan M; Qiu D; Liu L
    Hua Xi Yi Ke Da Xue Xue Bao; 1991 Sep; 22(3):303-6. PubMed ID: 1748416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neutropenia induced by low-dose captopril.
    Moussa Z; Schiano T; Spatoliatore G; Salman S
    N Y State J Med; 1992 May; 92(5):219-20. PubMed ID: 1614676
    [No Abstract]   [Full Text] [Related]  

  • 44. Treatment of advanced hypertension: choice of the effective antihypertensive drugs using angiotensin II antagonist.
    Abe K
    Jpn Circ J; 1981 Jul; 45(7):844-51. PubMed ID: 7021901
    [No Abstract]   [Full Text] [Related]  

  • 45. Captropril, angiotensin II, and sodium in blood-pressure regulation.
    Hoorntje SJ; Prins EJ; Donker AJ
    Lancet; 1979 May; 1(8126):1140. PubMed ID: 86859
    [No Abstract]   [Full Text] [Related]  

  • 46. [The renin-angiotensin-aldosterone system and antidiuretic hormone secretion during plasmapheresis in patients with high arterial hypertension refractory to drug therapy].
    Kukharchuk VV; Legkonogov AV; Kutsenko AI; Masenko VP; Arabidze GG
    Kardiologiia; 1988 Jan; 28(1):10-4. PubMed ID: 3357290
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Renin/angiotensin/aldosterone system in malignant hypertension.
    Naruse M; Demura H; Naruse K; Tanabe A; Yoshimoto T; Seki T
    Intern Med; 1997 Oct; 36(10):669-71. PubMed ID: 9372322
    [No Abstract]   [Full Text] [Related]  

  • 48. Malignant hypertension: the Brazilian experience.
    Ramos O
    Kidney Int; 1984 Aug; 26(2):209-17. PubMed ID: 6389957
    [No Abstract]   [Full Text] [Related]  

  • 49. Interplay between sodium and calcium regulatory hormones: a clinically relevant research field.
    Tomaschitz A; Pilz S
    Hypertension; 2014 Feb; 63(2):212-4. PubMed ID: 24191288
    [No Abstract]   [Full Text] [Related]  

  • 50. The pharmacological management of malignant hypertension.
    Gosse P; Boulestreau R; Brockers C; Puel C; Rubin S; Cremer A
    J Hypertens; 2020 Nov; 38(11):2325-2330. PubMed ID: 32649635
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Selected problems concerning the physiopathology of malignant hypertension].
    Januszewicz W; Rymaszewski Z
    Pol Tyg Lek; 1977 May; 32(18):693-6. PubMed ID: 866254
    [No Abstract]   [Full Text] [Related]  

  • 52. [Malignant hypertension].
    Tamura K; Sakai M; Tanaka Y; Tsurumi Y; Umemura S
    Nihon Rinsho; 2005 Mar; 63 Suppl 3():137-42. PubMed ID: 15813058
    [No Abstract]   [Full Text] [Related]  

  • 53. Initiation of captopril therapy: the first-dose effect.
    Black J; Hunt TL; Godley PJ
    J Clin Pharmacol; 1986; 26(7):539-40. PubMed ID: 3531250
    [No Abstract]   [Full Text] [Related]  

  • 54. [A difficult diagnostic case of malignant hypertension].
    Paschalis-Purtak K; Puciłowska B; Kabat M; Florczak E; Sznajderman M
    Pol Arch Med Wewn; 1993 Jan; 89(1):69-73. PubMed ID: 8479945
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Effect of inhibition of converting enzyme by captopril on arterial pressure, renin and aldosterone in essential hypertension].
    Posadas C; Sánchez G; Boyer JL; Delmar M; Serrano PA
    Arch Inst Cardiol Mex; 1982; 52(4):295-300. PubMed ID: 6291470
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Captopril in primary hypertension. Effects related to the renin-angiotensin-aldosterone and kallikrein-kinin systems.
    Ohman KP; Karlberg BE; Nilsson OR; Wettre S
    Acta Med Scand Suppl; 1981; 646():98-105. PubMed ID: 7018190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A discrepancy between the effects of a single oral dose of captopril on blood pressure, plasma renin activity, and serum angiotensin-converting enzyme levels.
    Lechi A; Covi G; Capuzzo MG; Lechi C; Minuz P; Delva P; Scuro LA
    Int J Clin Pharmacol Ther Toxicol; 1983 Nov; 21(11):569-74. PubMed ID: 6317579
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Brain Natriuretic Peptide Counteracting the Renin-angiotensin-aldosterone System in Accelerated Malignant Hypertension.
    Nakagawa H; Mizuno Y; Harada E; Morikawa Y; Kuwahara K; Saito Y; Yasue H
    Am J Med Sci; 2016 Nov; 352(5):534-539. PubMed ID: 27865304
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibition of the renin-angiotensin-aldosterone axis by low dose intravenous captopril as a treatment for accelerated phase hypertension.
    Padfield PL; Rademaker M; Atherden SM; Davies E; Edwards CR; Eglen A; Williams BC
    J Hypertens Suppl; 1985 Dec; 3(3):S475-7. PubMed ID: 2856771
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.